Financial Summary (All financials)
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 22.3 | 15.6 |
| Revenue growth | | | | | | | 43.6% | |
| Cost of goods sold | 33.2 | 0.0 | 65.4 | 0.0 | 0.0 | | 44.7 | 65.4 |
| Gross profit | -33.2 | 0.0 | -65.4 | 0.0 | 0.0 | | -22.3 | -49.9 |
| Gross margin | | | | | | | -100.0% | -320.7% |
| Research and development | 9.5 | 10.1 | 13.3 | 12.9 | 17.9 | | | |
| General and administrative | 6.3 | 5.5 | 7.2 | 6.0 | 5.5 | | 5.3 | 4.6 |
| EBIT | -24.3 | -19.2 | -12.6 | -27.8 | -33.5 | | -31.3 | -23.4 |
| EBIT margin | | | | | | | -140.2% | -150.3% |
| Pre-tax income | -16.6 | -16.2 | -19.1 | -25.6 | -29.8 | | -31.0 | -20.9 |
| Income taxes | 2.3 | 0.7 | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% |
| Net income | -18.9 | -16.9 | -19.1 | -29.6 | -43.9 | | -31.0 | 0.0 |
| Net margin | | | | | | | -138.7% | -0.2% |
| |
| Diluted EPS | ($4.70) | ($7.13) | ($8.82) | ($3.22) | ($62.95) | | ($469.52) | ($2.72) |
| Shares outstanding (diluted) | 4.0 | 2.4 | 2.2 | 9.2 | 0.7 | | 0.1 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|